Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics.
暂无分享,去创建一个
M. Pelizzo | D. Rubello | P. Colletti | F. Galuppini | G. Pennelli | M. Zane | I. Boschin | I. Merante Boschin
[1] Kieran Sheahan,et al. Lynch Syndrome: An Updated Review , 2014, Genes.
[2] Alexander M. Metcalf,et al. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Rodney J Scott,et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.
[4] C. Boland,et al. The History of Lynch Syndrome , 2013, Familial Cancer.
[5] P. Møller,et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts , 2013, Gut.
[6] C. Boland,et al. Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the Same EPCAM Deletion , 2011, The American Journal of Gastroenterology.
[7] D. Maglott,et al. Deciphering the colon cancer genes—report of the InSiGHT‐Human Variome Project Workshop, UNESCO, Paris 2010 , 2011, Human mutation.
[8] C. Boland,et al. Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. , 2010, Gastroenterology.
[9] J. Reid,et al. Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Heather Hampel,et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Potter,et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. , 2008, Gastroenterology.
[12] A. Karrenbeld,et al. Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum , 2008, Hereditary cancer in clinical practice.
[13] C. Boland,et al. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] F. Cetta,et al. Germ-line and Somatic Mutations of the APC Gene and/or ß Catenin Gene in the Occurrence of FAP Associated Thyroid Carcinoma , 2007, World Journal of Surgery.
[15] J. Jass. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.
[16] Harry Campbell,et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. , 2006, The New England journal of medicine.
[17] W. Frankel,et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.
[18] J. Potter,et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. , 2005, JAMA.
[19] R. Broaddus,et al. Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome , 2004, Modern Pathology.
[20] P. Møller,et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. , 2004, Gastroenterology.
[21] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[22] Daniel J Sargent,et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] P. Møller,et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Pelizzo,et al. Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. , 1999, The American journal of pathology.
[25] H T Lynch,et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.
[26] A. Fusco,et al. Genetic Alterations in Thyroid Carcinoma Associated with Familial Adenomatous Polyposis: Clinical Implications and Suggestions for Early Detection , 1998, World Journal of Surgery.
[27] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[28] H. Lynch,et al. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population , 1998, Diseases of the colon and rectum.
[29] C. Boland,et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.
[30] R. Kolodner,et al. Identification of mismatch repair genes and their role in the development of cancer. , 1995, Current opinion in genetics & development.
[31] Darryl Shibata,et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.
[32] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[33] S N Thibodeau,et al. Microsatellite instability in cancer of the proximal colon. , 1993, Science.
[34] J. Mecklin,et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.
[35] R. Elston,et al. Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource , 1985, Cancer.
[36] R. Elston,et al. Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). II. Biomarker studies , 1985, Cancer.
[37] F. Troncale,et al. Familial colonic cancer without antecedent polyposis. , 1984, Annals of internal medicine.
[38] C. Boland. Cancer family syndrome , 1978, The American Journal of Digestive Diseases.
[39] H. Lynch,et al. Cancer family “G” revisited: 1895‐1970 , 1971, Cancer.
[40] V. Glidzić,et al. [Hereditary nature of cancers of the colon]. , 1968, Bulletin du cancer.
[41] M. Kartagener,et al. [Familial incidence of double malignancies]. , 1966, Schweizerische medizinische Wochenschrift.
[42] S. Nilsson,et al. FAMILIAL DISPOSITION OF CANCER OF THE GASTROINTESTINAL TRACT. , 1965, Acta chirurgica Scandinavica.
[43] U. Heim,et al. [DOUBLE CANCER IN SIBLINGS. FAMILIAL ASSOCIATION OF CANCER OF THE GENITALIA AND INTESTINES]. , 1965, Swiss medical weekly.
[44] F. Heinzelmann. [ON A CANCER FAMILY. A CONTRIBUTION TO THE PROBLEM OF THE HEREDITARY ASPECTS OF COLONIC CARCINOMA]. , 1964, Helvetica chirurgica acta.
[45] T. Kluge. FAMILIAL CANCER OF THE COLON. , 1964, Acta chirurgica Scandinavica.
[46] D. Savage. A Family History of Uterine and Gastro-intestinal Cancer , 1956 .
[47] A. S. Warthin. HEREDITY WITH REFERENCE TO CARCINOMA: AS SHOWN BY THE STUDY OF THE CASES EXAMINED IN THE PATHOLOGICAL LABORATORY OF THE UNIVERSITY OF MICHIGAN, 1895-1913 , 1913 .
[48] Julie O. Culver,et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. , 2011, The Lancet. Oncology.
[49] E. Urso,et al. A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors. , 2010, Cancer biomarkers : section A of Disease markers.
[50] Suet Yi Leung,et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.
[51] R. Houlston,et al. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome. , 2009, Gastroenterology.
[52] Jeffrey R. Botkin,et al. Summary of Recommendations: The Evaluation of Genomic Applications , 2022 .
[53] F. Cetta,et al. Germ-line and somatic mutations of the APC gene and/or b catenin gene in the occurrence of FAP associated thyroid carcinoma. Author's reply , 2007 .
[54] S. Olschwang,et al. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. , 2000, The Journal of clinical endocrinology and metabolism.
[55] J. Knezetic,et al. A century of progress in hereditary nonpolyposis colorectal cancer (lynch syndrome) , 1999, Diseases of the colon and rectum.
[56] J. A. Bargen,et al. FAMILIAL TRENDS IN HUMAN CANCER , 1941 .